Digital Workshop: Autodoc Launches the Autodoc Club Innovative Platform
Autodoc, the benchmark in the online retailing for car spare parts in Europe, is now offering its customers and interested parties an innovative platform for the maintenance of their own car under the name “Autodoc Club”. Thanks to its features, it is unique on the market. The platform, which is available in 26 European countries, contains over 1,300 professional PDF repair instructions in all national languages, plus 2,240 detailed video tutorials. In addition, there is a whole range of other useful functions, such as the integrated maintenance protocol for your own car. This opens up new possibilities for planning repairs and controlling costs. The Autodoc Club app is scheduled for release for Android and iOS operating systems at the beginning of 2020, and bundles on mobile devices all the Club website functions for smartphone and tablet users.
One-stop shop for advice, service and parts
Autodoc’s “Autodoc Club” now offers its customers an innovative platform that provides a wide range of services related to the repair and maintenance of cars. In addition to instructions in the form of PDFs and video tutorials, Autodoc Club offers various other features: users can not only store their car model in their profile, but also keep a maintenance log, receive reminders for the replacement of consumables or save workshop information.
The main component of the new Autodoc Club is a collection of over 1,300 PDF repair manuals and 2,240 video tutorials on individual repairs. A search function enables the customer to find the right manual for their car for the upcoming project. If a manual is not yet available, it can be requested directly from the Autodoc specialists.
Professional advice and convenient purchase of spare parts
The instructions provide direct access to the Autodoc online shop. The user can order all required parts conveniently in the spare parts dealer’s online shop. If a tool is missing, it can also be ordered directly in the online shop. In case of questions regarding repairs or spare parts, the customer can contact specialists such as car mechanics or technicians directly in the forum at any time. Autodoc Club therefore offers an integrated one-stop solution for car owners who want to repair their car themselves or obtain comprehensive information and buy spare parts directly and inexpensively.
“For the layman, car parts are mostly products that require explanation. From our experience, we know that many customers often have questions and need advice from experts. We now offer such support with the easy-to-use and integrated Autodoc Club platform. Every car owner can see how a repair is done, get help and decide for themselves what support they need from their local workshop. In any case, they can always order parts and tools conveniently from the Autodoc online shop without having to search the Internet for them”, explains Autodoc Managing Director, Alexej Erdle.
Free platform for car-related services
Additional features such as a maintenance log and a reminder function for changing consumables round off the offer and also help to avoid unnecessary costs. As a result, your car always stays in top condition. In the personal area, the user can also store vehicle documents, vehicle insurance policies and their own notes, so that all documents relating to their car are always at hand. And from the beginning of 2020, this will also be possible when on the go and travelling using your smartphone.
The use of the platform is unlimited and independent of placing an order. The creation of a free user account is only required for the personal assistant. Existing registration data for the Autodoc online shop also work on the new portal. Any car data already entered in the store account will also be transferred automatically when registering for Autodoc Club with the same account.
About Autodoc
Autodoc is Europe's leading online dealer for car spare parts. As the fastest-growing company in this sector with sales growth of 63% in the financial year 2018 to around EUR 415 million (2017: EUR 254 million), Autodoc aims to further expand its position. Thanks to its successful expansion, Autodoc is now represented in 25 other European countries in addition to Germany. Autodoc pursues a strong customer focus through social media campaigns, technical support in the respective national language and a current demand-oriented range of almost 2.5 million products from 545 brand manufacturers for 128 car brands. Autodoc GmbH is based in the Berlin district of Lichtenberg and is fully owner-managed. In addition to its headquarters, the company opened a representative office on Kurfürstendamm in May 2019.
The original source-language text of this announcement is the official, authoritative version. Translations are provided as an accommodation only, and should be cross-referenced with the source-language text, which is the only version of the text intended to have legal effect.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20191029005090/en/
Contact information
Thomas Casper
Head of Press and Public Relations & Communication
Tel.: +49-30-2084-78-237
E-mail: t.casper@autodoc.eu
www.autodoc.de
cometis AG
Matthias Kunz
Tel.: +49-611-20-585-564
kunz@cometis.de
www.cometis.de
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Deciphera Announces Oral Presentation of Positive Topline Results from Phase 2a Study of Sapablursen in Polycythemia Vera at the 67 th American Society of Hematology (ASH) Annual Meeting6.12.2025 16:30:00 EET | Press release
Deciphera Pharmaceuticals, a member of Ono Pharmaceutical Co., Ltd. (Headquarters: Osaka, Japan; President and COO: Toichi Takino; “Ono”), today announced the oral presentation of positive results from the Phase 2a IMPRSSION study of sapablursen in patients with polycythemia vera (PV) at the 67th American Society of Hematology (ASH) Annual Meeting, taking place December 6-9, 2025, in Orlando, FL. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251206361611/en/ The results were presented by Ionis Pharmaceuticals, who discovered and developed sapablursen and conducted the IMPRSSION study. In March 2025, Ionis and Ono entered into a license agreement in which Ono obtained exclusive global rights for the development and commercialization of sapablursen. “In the treatment of PV, phlebotomy and cytoreductive therapy are performed as treatments for preventing thrombosis. Phlebotomy is the most common treatment for PV, in which blood
Protagonist and Takeda Present Longer-Term Data at ASH 2025 Showing Rusfertide Delivers Durable Response and Hematocrit Control in Polycythemia Vera6.12.2025 16:30:00 EET | Press release
Protagonist Therapeutics, Inc. (“Protagonist”) (NASDAQ:PTGX) and Takeda (TSE:4502/NYSE:TAK) announce that new 52-week results from the pivotal Phase 3 VERIFY study evaluating rusfertide in patients with polycythemia vera (PV) will be presented in an oral presentation at the 67th American Society of Hematology (ASH) Annual Meeting and Exposition. These findings further reinforce rusfertide’s efficacy and safety and demonstrate durability of response, with 61.9% of patients continuously treated with rusfertide maintaining absence of phlebotomy eligibility from baseline to Week 52. “The 52-week data demonstrated the sustained efficacy of rusfertide, reducing the need for patients to receive phlebotomy while maintaining hematocrit control,” said Dr. Andrew T. Kuykendall, M.D., VERIFY Lead Investigator and Associate Member in the Department of Hematology at Moffitt Cancer Center. “The 32-week VERIFY primary results were already promising, and this deeper understanding of the durability of r
Vertex Presents New Data on CASGEVY ® , Including First-Ever Data in Children Ages 5-11 Years, at the American Society of Hematology Annual Meeting and Announces Plan for Global Regulatory Submissions6.12.2025 14:01:00 EET | Press release
Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced data from multiple studies demonstrating the clinical benefits of CASGEVY® (exagamglogene autotemcel) in people ages 5 years and older living with severe sickle cell disease (SCD) or transfusion-dependent beta thalassemia (TDT). The results, including the first presentation of clinical data from pivotal studies in children ages 5-11 years, and longer-term data from the pivotal studies of people with severe SCD and TDT ages 12 years and older, will be presented at the American Society of Hematology (ASH) Annual Meeting. CASGEVY is currently approved for eligible people ages 12 years and older with SCD or TDT in the United States, Great Britain, the European Union, the Kingdom of Saudi Arabia, the Kingdom of Bahrain, Kuwait, Qatar, Canada, Switzerland and the United Arab Emirates. “These results — the first clinical data ever presented on any genetic therapy for children ages 5-11 years with SCD — again demonstrate the tr
Leading Global Scientists Gather at Tengchong Scientists Forum to Explore Innovative Pathways in Frontier Technologies6.12.2025 13:31:00 EET | Press release
The 2025 Tengchong Scientists Forum opened on Saturday in southwest China’s Yunnan Province, convening leading scientists and academic figures to examine innovation across frontier fields including artificial intelligence, biodiversity and quantum technology. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251205499197/en/ Opening ceremony of Tengchong Scientists Forum on 6th December, 2025 Notable participants include Nobel Physics laureate Konstantin Novoselov, Fields Medalist Efim Zelmanov and Turing Award winner Andrew Chi-Chih Yao, who join 127 academicians, 77 university presidents from China and abroad, over 400 scholars and more than 600 entrepreneurs and financiers. The gathering aims to deepen collaboration between cutting-edge research and industrial development. Under the theme “Science · AI changing the World,” the forum features ten sub-forums, academic sessions and thematic events supporting major cooperation p
Lattice Wins 2025 Global Semiconductor Alliance Award6.12.2025 01:49:00 EET | Press release
Lattice Semiconductor (NASDAQ: LSCC), the low power programmable leader, today announced that it was selected as ‘Most Respected Public Semiconductor Company’ at the 2025 Global Semiconductor Alliance (GSA) Awards. The GSA awards recognize companies that have demonstrated excellence through their success, vision, strategy, and future opportunities in the industry as determined by votes from GSA members. “We are honored to be recognized by the Global Semiconductor Alliance and our peers as one of 2025’s most respected public semiconductor companies. This recognition reflects the dedication of the Lattice team and the trust of our customers, partners, suppliers, and investors. Looking ahead, we remain laser-focused on driving innovation and strengthening our role as the trusted low power programmable leader for semiconductor and system solutions,” said Ford Tamer, Chief Executive Officer, Lattice Semiconductor. The annual GSA Awards celebrate the accomplishments of the semiconductor indu
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom